Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Thinking "Seriously, Deeply" About Range Of Approval Strategies – Hamburg

Jul 04 2011

• By Cathy Kelly

Related Content

No More Easy Vaccines, Merck's Gerberding Says In Call For Collaboration

Jun 27 2011

Sentinel Initiative Needs Better Defined Goals, Outside Review Concludes

May 18 2011

Lilly Hopes To Score Novel Compounds Early By Offering To Screen Discoveries

Jun 15 2009

BIO’s "Big Ideas" For FDA Reform Are Too Big For PDUFA

Jul 04 2011

NIH Translational Center To Study Cell-Based Toxicity Tests, Offer Industry Grants

Jul 04 2011

<i>Avastin</i>’s Breast Cancer Claim: Will FDA’s Hamburg Take A Middle Road?

Jul 04 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window